A Double Blinded Randomized Control Trial in Outcomes for Lumbar Decompressions With Use of Liposomal Bupivicaine
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 2
SUMMARY
Evaluate the benefit of using liposomal bupivicaine in lumbar laminectomies in terms of length of stay, IV narcotic use, 30-day narcotic use, visual analog score (VAS) and 30-day readmissions
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Male or Female
• Adult (≥18 yo)
• Lumbar stenosis
Locations
United States
Colorado
University of Colorado Anschutz Medical Campus
RECRUITING
Aurora
Contact Information
Primary
Jens-Peter Witt, MD, PhD
peter.witt@cuanschutz.edu
303-724-2306
Backup
Akal Sethi, MD
akal.sethi@cuanschutz.edu
303-724-1995
Time Frame
Start Date: 2019-09-08
Estimated Completion Date: 2025-01
Participants
Target number of participants: 100
Treatments
Active_comparator: Liposomal Bupivicaine
Treatment with liposomal bupivicaine
Active_comparator: Standard Local Anesthestic
Treatment with Standard Local Anesthestic
Related Therapeutic Areas
Sponsors
Leads: University of Colorado, Denver